News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,716 Results
Type
Article (87568)
Company Profile (740)
Press Release (774391)
Multimedia
Podcasts (199)
Webinars (29)
Section
Business (232969)
Career Advice (4146)
Deals (39878)
Drug Delivery (146)
Drug Development (91219)
Employer Resources (205)
FDA (18294)
Job Trends (17428)
News (397178)
Policy (39863)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3006)
Academic (1)
Accelerated approval (33)
Adcomms (30)
Allergies (129)
Alliances (56886)
ALS (163)
Alzheimer's disease (1776)
Antibody-drug conjugate (ADC) (323)
Approvals (18443)
Artificial intelligence (556)
Autoimmune disease (169)
Automation (37)
Bankruptcy (402)
Best Places to Work (12573)
BIOSECURE Act (23)
Biosimilars (206)
Biotechnology (457)
Bladder cancer (146)
Brain cancer (54)
Breast cancer (597)
Cancer (4558)
Cardiovascular disease (367)
Career advice (3571)
Career pathing (42)
CAR-T (299)
CDC (39)
Celiac Disease (2)
Cell therapy (788)
Cervical cancer (30)
Clinical research (76414)
Collaboration (1732)
Company closure (4)
Compensation (1038)
Complete response letters (69)
COVID-19 (2952)
CRISPR (93)
C-suite (873)
Cystic fibrosis (145)
Data (5791)
Decentralized trials (2)
Denatured (74)
Depression (126)
Diabetes (422)
Diagnostics (7076)
Digital health (40)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (265)
Drug pricing (176)
Drug shortages (21)
Duchenne muscular dystrophy (207)
Earnings (99114)
Editorial (60)
Employer branding (25)
Employer resources (174)
Events (133472)
Executive appointments (985)
FDA (20995)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1418)
Gene editing (194)
Generative AI (54)
Gene therapy (626)
GLP-1 (1004)
Government (5346)
Grass and pollen (4)
Guidances (359)
Healthcare (20833)
HIV (50)
Huntington's disease (47)
IgA nephropathy (82)
Immunology and inflammation (277)
Immuno-oncology (63)
Indications (94)
Infectious disease (3200)
Inflammatory bowel disease (206)
Inflation Reduction Act (15)
Influenza (107)
Intellectual property (217)
Interviews (816)
IPO (17838)
IRA (47)
Job creations (5200)
Job search strategy (2867)
JPM (68)
Kidney cancer (17)
Labor market (97)
Layoffs (643)
Leadership (40)
Legal (10100)
Liver cancer (88)
Longevity (15)
Lung cancer (629)
Lymphoma (353)
Machine learning (41)
Management (66)
Manufacturing (774)
MASH (171)
Medical device (14633)
Medtech (14673)
Mergers & acquisitions (22845)
Metabolic disorders (1209)
Multiple sclerosis (157)
NASH (22)
Neurodegenerative disease (342)
Neuropsychiatric disorders (86)
Neuroscience (2991)
Neurotech (1)
NextGen: Class of 2026 (7687)
Non-profit (5099)
Now hiring (68)
Obesity (580)
Opinion (333)
Ovarian cancer (156)
Pain (170)
Pancreatic cancer (197)
Parkinson's disease (272)
Partnered (34)
Patents (424)
Patient recruitment (461)
Peanut (57)
People (66709)
Pharmaceutical (133)
Pharmacy benefit managers (23)
Phase 1 (23654)
Phase 2 (33225)
Phase 3 (24943)
Pipeline (4872)
Policy (307)
Postmarket research (3545)
Preclinical (10633)
Press Release (72)
Prostate cancer (221)
Psychedelics (53)
Radiopharmaceuticals (288)
Rare diseases (850)
Real estate (7434)
Recruiting (81)
Regulatory (28517)
Reports (66)
Research institute (2711)
Resumes & cover letters (652)
Rett syndrome (21)
RNA editing (21)
RSV (74)
Schizophrenia (146)
Series A (245)
Series B (180)
Service/supplier (26)
Sickle cell disease (92)
Special edition (28)
Spinal muscular atrophy (175)
Sponsored (48)
Startups (4328)
State (2)
Stomach cancer (15)
Supply chain (87)
Tariffs (85)
The Weekly (123)
Vaccines (1055)
Venture capital (94)
Weight loss (378)
Women's health (85)
Worklife (22)
Date
Today (36)
Last 7 days (504)
Last 30 days (1836)
Last 365 days (27611)
2026 (3192)
2025 (27936)
2024 (35270)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1281)
Alabama (85)
Alaska (6)
Arizona (313)
Arkansas (11)
Asia (51294)
Australia (9023)
California (10509)
Canada (2789)
China (1116)
Colorado (372)
Connecticut (413)
Delaware (321)
Europe (117571)
Florida (1484)
Georgia (289)
Hawaii (4)
Idaho (66)
Illinois (754)
India (60)
Indiana (506)
Iowa (22)
Japan (377)
Kansas (134)
Kentucky (26)
Louisiana (26)
Maine (63)
Maryland (1331)
Massachusetts (7832)
Michigan (308)
Minnesota (507)
Mississippi (5)
Missouri (94)
Montana (35)
Nebraska (29)
Nevada (117)
New Hampshire (66)
New Jersey (2800)
New Mexico (31)
New York (2759)
North Carolina (1484)
North Dakota (9)
Northern California (5152)
Ohio (295)
Oklahoma (18)
Oregon (51)
Pennsylvania (2020)
Puerto Rico (24)
Rhode Island (42)
South America (1661)
South Carolina (23)
South Dakota (1)
Southern California (4052)
Tennessee (111)
Texas (1514)
United States (36927)
Utah (243)
Vermont (1)
Virginia (202)
Washington D.C. (55)
Washington State (870)
West Virginia (3)
Wisconsin (99)
Wyoming (2)
862,716 Results for "warp drive bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
Uptick in Dealmaking, Chinese Partnerships Drive Biotech’s Comeback
Biotech’s slump may finally be over in 2026. In interviews with
BioSpace
, Zymeworks’ CEO Ken Galbraith and Zai Lab’s President and COO Josh Smiley explain what’s fueling the comeback.
December 17, 2025
·
3 min read
·
Jennifer Smith-Parker
Press Releases
LIfT BioSciences Announces CEO Transition to Drive Next Phase of Growth with Neutrophil-based Therapies
January 7, 2026
·
4 min read
Deals
Inside the 2026 Biotech Landscape: Innovation, Investment and Global Momentum
In this episode of Denatured, Jennifer Smith-Parker speaks to Kenneth Galbraith,
CEO of Zymeworks and Josh Smiley, president and COO of Zai Lab, about how renewed confidence is driving biotech entering 2026.
December 18, 2025
·
1 min read
·
BioSpace Insights
Employer Resources
Report: Driving Biopharma Engagement
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. Learn how strategic insights and targeted outreach can turn awareness into high-converting leads.
August 11, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Driving Biopharma Commercial Success through Redefined CRDMO Partnerships
Dr. Chris Chen, CEO of WuXi Biologics, answers questions about recent developments, novel platforms, and how to stay ahead of rapid developments to ensure quality, reliability and speed of delivery
November 14, 2025
·
1 min read
Press Releases
Cadenza Bio Announces Peer-Reviewed Study Showing Oral, Brain-Penetrant ERβ Ligands Drive Remyelination and Functional Recovery in MS Models
October 10, 2025
·
4 min read
THOUGHT LEADERSHIP
Webinar: Driving Biopharma Engagement: How Thought Leadership and Marketing Fuel Lead Generation
Establishing trust through thought leadership is no longer optional in today’s cautious biopharma market. This webinar will show leaders how strategic insights and targeted outreach can turn awareness into high-converting leads. Watch now.
September 10, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Ultima Genomics Strengthens Oncology Leadership to Drive Clinical Growth
February 11, 2026
·
3 min read
Press Releases
Hinge Bio Expands Leadership Team to Drive Clinical Development of GEM-DIMER™ Programs and Announces Publication in Scientific Reports
September 4, 2025
·
6 min read
Press Releases
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion
December 15, 2025
·
4 min read
1 of 86,272
Next
